Gary H. Lyman

Gary H. Lyman

Corporate Officer/Principal en Duke Comprehensive Cancer Center .

78 años
Consumer Services
Commercial Services
Health Technology

Perfil

Gary H.
Lyman
is currently the Director of Comparative Effectiveness at Duke Comprehensive Cancer Center and a Professor at the University of Washington.
He previously held positions as a Professor and Director of Health Services at the University of Rochester, Co-Director at Fred Hutchinson Cancer Research Center, Professor and Director of Cancer Center at Albany Medical College, Professor at Duke University, the University of South Florida, H.
Lee Moffitt Cancer Center & Research Institute, Inc., USF Health Morsani College of Medicine, and Duke Cancer Institute.
He also served as an Independent Director at Generex Biotechnology Corp.
from 2017 to 2019.
Lyman received his undergraduate and doctorate degrees from the State University of New York at Buffalo.

Cargos activos de Gary H. Lyman

EmpresasCargoInicio
Corporate Officer/Principal -
Corporate Officer/Principal -
Todos los cargos activos de Gary H. Lyman

Antiguos cargos conocidos de Gary H. Lyman.

EmpresasCargoFin
GENEREX BIOTECHNOLOGY CORPORATION Director/Miembro de la Junta 21/02/2019
Corporate Officer/Principal -
Rochester Christian University Corporate Officer/Principal -
Albany Medical College Corporate Officer/Principal -
University of South Florida Corporate Officer/Principal -
Ver el detalle de la experiencia de Gary H. Lyman.

Formación de Gary H. Lyman.

State University of New York at Buffalo Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Gary H. Lyman.

Relaciones

100 +

Relaciones de 1er grado

12

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas5

Health Technology

Commercial Services

Commercial Services

Health Services

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA